Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

Milestone Pharma Announces Approval Of Etripamil Nasal Spray In China; Triggers Milestone Payment

(RTTNews) - Milestone Pharmaceuticals Inc. (MIST) announced that China's National Medical Products Administration has approved etripamil nasal spray for the treatment of paroxysmal supraventricular tachycardia in adults. The NMPA decision marks the first regulatory approval of e

We haven't written up this one. Nasdaq Markets has the full story — the link below goes straight to it.

Read the original at nasdaq.com →

More in Health & Medicine

More from Thursday 3 September →